US 10875920
Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof
granted A61KA61K39/395A61P
Quick answer
US patent 10875920 (Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof) held by The Board of Regents of the University of Texas System expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K39/395, A61P, A61P1/00, A61P1/16